The role of sarcosine metabolism in prostate cancer progression.

Neoplasia (New York, N.Y.) 2013 May

filter terms:

Metabolomic profiling of prostate cancer (PCa) progression identified markedly elevated levels of sarcosine (N-methyl glycine) in metastatic PCa and modest but significant elevation of the metabolite in PCa urine. Here, we examine the role of key enzymes associated with sarcosine metabolism in PCa progression. Consistent with our earlier report, sarcosine levels were significantly elevated in PCa urine sediments compared to controls, with a modest area under the receiver operating characteristic curve of 0.71. In addition, the expression of sarcosine biosynthetic enzyme, glycine N-methyltransferase (GNMT), was elevated in PCa tissues, while sarcosine dehydrogenase (SARDH) and pipecolic acid oxidase (PIPOX), which metabolize sarcosine, were reduced in prostate tumors. Consistent with this, GNMT promoted the oncogenic potential of prostate cells by facilitating sarcosine production, while SARDH and PIPOX reduced the oncogenic potential of prostate cells by metabolizing sarcosine. Accordingly, addition of sarcosine, but not glycine or alanine, induced invasion and intravasation in an in vivo PCa model. In contrast, GNMT knockdown or SARDH overexpression in PCa xenografts inhibited tumor growth. Taken together, these studies substantiate the role of sarcosine in PCa progression.

Citation

Amjad P Khan, Thekkelnaycke M Rajendiran, Bushra Ateeq, Irfan A Asangani, Jyoti N Athanikar, Anastasia K Yocum, Rohit Mehra, Javed Siddiqui, Ganesh Palapattu, John T Wei, George Michailidis, Arun Sreekumar, Arul M Chinnaiyan. The role of sarcosine metabolism in prostate cancer progression. Neoplasia (New York, N.Y.). 2013 May;15(5):491-501